UBE (4208) Q3 2026 earnings summary

Executive summary

• Net sales for the 3rd quarter FY2025 decreased 7.6% year-over-year to ¥332.2 billion, mainly due to weak performance in Polymers & Chemicals and Machinery, despite contributions from the newly acquired Urethane Systems Business.

• Operating profit rose 52.0% to ¥14.5 billion, and ordinary profit more than doubled to ¥30.3 billion, driven by lower depreciation, absence of large-scale maintenance, and increased foreign exchange gains.

• Profit attributable to owners of parent swung from a ¥19.1 billion loss to a ¥21.1 billion profit, as no extraordinary losses were incurred this period.

• Segment reclassification expanded from four to six segments, including High Performance Urethane and Pharmaceuticals as independent segments.

Financial highlights

• EBITDA increased 15.5% year-over-year to ¥35.0 billion.

• Net income per share improved from a loss of ¥196.93 to a gain of ¥216.99.

• Shareholders' equity rose to ¥424.8 billion, and total assets increased to ¥929.5 billion.

• Interest-bearing debt increased to ¥360.3 billion.

• Gross profit increased to ¥77.1 billion from ¥63.6 billion year-over-year.

Outlook and guidance

• Full-year net sales forecast is ¥490.0 billion, with operating profit expected at ¥25.0 billion and profit attributable to owners of parent at ¥32.3 billion.

• Net income per share forecasted at ¥283.15.

• Progress rates for 3Q reached 67.8% for net sales and 58.0% for operating profit.

• Segment forecasts indicate continued growth in High Performance Urethane and Polymers & Chemicals in the second half.

• No revision to the latest forecast; segment-level forecasts updated in prior disclosures.